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doi:10.1016/j.jfma.2011.09.002In May 2011, the illegal use of the phthalate plasticizer di(2-ethylhexyl) phthalate in clouding
agents for use in foods and beverages was reported in Taiwan. This food scandal has caused
shock and panic among the majority of Taiwanese people and has attracted international
attention. Phthalate exposure is assessed by ambient monitoring or human biomonitoring.
Ambient monitoring relies on measuring chemicals in environmental media, foodstuff and
consumer products. Human biomonitoring determines body burden by measuring the chemi-
cals, their metabolites or specific reaction products in human specimens. In mammalian devel-
opment, the fetus is set to develop into a female. Because the female phenotype is the
default, impairment of testosterone production or action before the late phase may lead to
feminizing characteristics. Phthalates disrupt the development of androgen-dependent struc-
tures by inhibiting fetal testicular testosterone biosynthesis. The spectrum of effects obtained
following perinatal exposure of male rats to phthalates has remarkable similarities with the
human testicular dysgenesis syndrome. Epidemiological studies have suggested associations
between phthalate exposure and shorter gestational age, shorter anogenital distance, shorter
penis, incomplete testicular descent, sex hormone alteration, precocious puberty, pubertal
gynecomastia, premature thelarche, rhinitis, eczema, asthma, low birth weight, attention
deficit hyperactivity disorder, low intelligence quotient, thyroid hormone alteration, and
hypospadias in infants and children. Furthermore, many studies have suggested associations
between phthalate exposure and increased sperm DNA damage, decreased proportion of sperm
with normal morphology, decreased sperm concentration, decreased sperm morphology, sex
hormone alteration, decreased pulmonary function, endometriosis, uterine leiomyomas,
breast cancer, obesity, hyperprolactinemia, and thyroid hormone alteration in adults. Finally,of Nephrology, Chang Gung Memorial Hospital, 199 Tung Hwa North Road, Taipei 105, Taiwan.
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672 T.-H. Yen et al.Figure 1 Phthalate food scandal
decyl phthalate; DnOP Z di-n-octythe number of phthalate-related scientific publications from Taiwan has increased greatly over
the past 5 years, which may reflect the health effects from the illegal addition of phthalate
plasticizer to clouding agent in foodstuff over the past two decades.
Copyright ª 2011, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
In Taiwan, phthalate esters have recently attracted the
special attention of the medical community, regulatory
agencies and the general public as a result of their wide-
spread illegal use as food and beverage additives. The term
phthalates describes a class of chemicals that are dialkyl- or
alkylarylesters of 1,2-benzenedicarboxylic acid. Their
industrial applications are related to the length of the ester
chain. The long-chain or high-molecular-weight phthalates
di(2-ethylhexyl) phthalate (DEHP), di-iso-nonyl phthalate
(DiNP), di-iso-decyl phthalate (DiDP) and dipropylheptyl
phthalate (DPHP) are primarily used in polyvinyl chloride
(PVC) polymer and plastisol applications.1 They can be found
in building and construction materials, cables and wires,
floorings, clothing, furnishings, car interiors and car under-
body coatings, toys and also food contact materials. DEHP,
which had been themost commonly used phthalate for many
years, has been substituted, for the most part by DiNP and
DiDP/DPHP. Short-chain or low-molecular-weight phtha-
lates, such as dimethyl phthalate (DMP), diethyl phthalate
(DEP), butyl-benzyl phthalate (BBzP), di-n-butyl phthalate
(DnBP) and di-iso-butyl phthalate (DiBP), are often used also
in non-PVC applications, for example, personal-care prod-
ucts, paints, adhesives or enteric-coated tablets.1 As the
phthalate plasticizers are not chemically bound to PVC, they
can leach, migrate or evaporate into the indoor air and
atmosphere, foodstuffs, and other materials.2 Consumer
products containing phthalates can result in human exposure
through direct contact and use, through indirect leaching
into other products, or via general environmentalin Taiwan. DEHP Z di(2-ethylh
l phthalate.contamination. Humans are exposed by ingestion, inhala-
tion, and dermal exposure during their whole lifetime,
including during intrauterine development.2
Phthalate food scandal in Taiwan
In May 2011, the illegal use of the phthalate plasticizer
DEHP in clouding agents as additives in foods and beverages
was reported in Taiwan (Fig. 1). The Food and Drug
Administration discovered a clouding agent that was man-
ufactured and sold by Yu Shen Chem. Co. Ltd. as a food
additive containing DEHP, and immediately launched an
investigation.3 Affected businesses were ordered to recall
and remove the tainted products from store shelves
nationwide. While carrying out a comprehensive island-
wide check, the Food and Drug Administration found that
a clouding agent produced by Pin Han Perfumery Co. Ltd.
contained another plasticizer, DiNP, and immediately
detained and sealed the tainted products, as well as iden-
tified the marketing channels for the products.3 Efforts
have been made to track down the downstream businesses
and prevent plasticizer-tainted products from entering the
market.
Clouding agents are legal food additives that have been
used for many years. They are normally made of gum
arabic, emulsifying agents, palm oil, and other food addi-
tives. DEHP and DiNP are categorized as industrial plasti-
cizers, which should not be added to food. After a criminal
investigation, it was found that the illegal clouding agents
to which DEHP had been added appeared as early as two
decades ago, and the color of tainted clouding agents wasexyl) phthalate; DiNP Z di-iso-nonyl phthalate; DiDP Z di-iso-
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agents made with DEHP could be preserved for up to half
a year longer than those made using palm oil.4 Diluting
DEHP-laced clouding agents could allow it to be added to
more drinks, and thus, increase profits.4
After discovering that clouding agents from Yu Shen
Chem. Co. Ltd. and Pin Han Perfumery Co. Ltd. contained
DEHP and DiNP, respectively, the Food and Drug Adminis-
tration immediately launched investigations to track down
where the clouding agents had been sold; all products from
the above two companies containing clouding agents were
detained, while those found in sales outlets were taken off
the shelves for public health protection. The Department of
Health3 announced that starting on May 31, 2011 (D-Day),
all ingredients, semi-finished products, and products con-
taining clouding agents confirmed by the Department of
Health as containing plasticizers must be taken off the
shelves and recalled; this included sports drinks, fruit
beverages, tea beverages, jam, fruit pulp and fruit jelly,
and food supplements in capsules, tablets or powders. The
products will be allowed back on the shelf after the busi-
nesses provide product safety certifications verifying that
the products contain no plasticizers. During its ongoing
investigations of DEHP- and DiNP-containing clouding
agents from Yu Shen Chem. Co. Ltd. and Pin Han Perfumery
Co. Ltd., respectively, the Food and Drug Administration
notified the World Health Organization and the European
Union Rapid Alert System of Food and Feed of such products
and the relevant companies.3 Simultaneously, countries
that have imported the tainted products have also been
notified to take responsive measures. Nevertheless, this
scandal has caused shock and panic among the majority
of Taiwanese people and has attracted international
attention.Table 1 Commonly used phthalate esters and their primary
metabolites.
Compound Primary metabolite
Low molecular weight phthalate
Dimethyl phthalate Mono-methyl phthlate
Diethyl phthalate Mono-ethyl phthalate
Di-cyclohexyl phthalate Mono-cyclohexyl phthala
Di-n-pentyl phthalate Mono-n-pentyl phthalate
Butyl-benzyl phthalate Mono-benzyl phthalate
Di-iso-butyl phthalate Mono-iso-butyl phthalate
Di-n-butyl phthalate Mono-n-butyl phthalate
High molecular weight phthalate
Di(2-ethylhexyl) phthalate Mono-(2-ethylhexyl) phth
Di-n-octyl phthalate Mono-n-octyl phthalate
Di-iso-nonyl phthalate Mono-iso-nonyl phthalate
Di-iso-decyl phthalate and
Dipropylheptyl phthalate
Mono-iso-decyl phthalateMetabolism of phthalates
The metabolism and elimination of phthalates are
complex.5 In a first rapid step, which can occur at various
stages/sites in the body (e.g., mouth or skin, stomach,
intestines, or blood), the phthalate diester is cleaved into
the respective hydrolytic monoester. In a second step, the
alkyl chain of the resulting hydrolytic monoester can be
modified by various oxidation reactions. In a third step,
both the hydrolytic monoester and the oxidized secondary
metabolites can be conjugated with glucuronic acid and
finally excreted in urine. The extent of oxidative modifi-
cation increases relative to the alkyl chain length of the
phthalate monoester. Oxidative metabolites are more
water soluble than the corresponding hydrolytic mono-
esters, which, in turn, have decreased water solubility
when the length of the alkyl chain increases. Therefore,
low-molecular-weight phthalates are mostly metabolized
to their hydrolytic monoesters.5 By contrast, high-
molecular-weight phthalates with 8 carbons in the alkyl
chain metabolize to their hydrolytic monoesters, which are
extensively transformed to oxidative products.5 Selected
phthalates and their respective metabolites (as biomarkers
of exposure) that are currently being investigated in
epidemiological studies are summarized in Table 1.
Phthalate exposure assessment
Ambient monitoring relies on measuring chemicals in envi-
ronmental media, foodstuff and consumer products.5 Based
on these data, together with survey/questionnaire data on
personal lifestyle, product use, and food consumption,
scenarios representing realistic exposure situations are(hydrolytic monoester) and secondary (oxidized monoester)
Secondary metabolite
te
3OH-Mono-methylpropyl phthalate
3OH-Mono-n-butyl phthalate
3carboxy-Mono-propyl phthalate
alate 5OH-Mono-(2-ethylhexyl) phthalate
5oxo-Mono-(2-ethylhexyl) phthalate
5carboxy-Mono-(2-ethylhexyl) phthalate
3carboxy-Mono-propyl phthalate
7OH-Mono-methyloctyl phthalate
7oxo-Mono-methyloctyl phthalate
7carboxy-Mono-methyheptyl phthalate
6OH-Mono-propylheptyl phthalate
6oxo-Mono-propylheptyl phthalate
Mono(2,7-methyl-7-carboxyheptyl)
phthalate (mono-carboxyisooctyl phthalate)
674 T.-H. Yen et al.generated to calculate the range in daily exposure through
these pathways. Combining these external exposure esti-
mates with organ- and situation-specific uptake rates, the
daily internalexposure in (mg/kg/day)canbecalculated.The
main aim of these models, however, is to estimate possible
contributions of different pathways to the total exposure and
not to estimate reliably the overall or average extent of
exposure of the general population. However, the ubiquitous
presenceofphthalates in theenvironmentposesananalytical
challenge known as the phthalate blank problem.5
Another way to perform an exposure assessment is
human biomonitoring.5 Human biomonitoring determines
internal exposure or body burden by measuring the chem-
icals, their metabolites or specific reaction products in
human specimens. Most of the biomarkers used in human
plasticizer biomonitoring are specific metabolites gener-
ated in the human body (Table 1), therefore, they are not
prone to environmental phthalate contamination.5
Although phthalate monoester metabolites can be
measured in many biological samples such as urine, serum,
breast milk, saliva, seminal fluid, and amniotic fluid, they
are most commonly measured in urine using high-
performance liquid chromatography with tandem mass
spectrometry. Serum concentrations of phthalates have
been measured, but phthalates have been measured in
much greater quantities in urine as compared with serum.6
This may be due to the fact that serum contains enzymes
that convert diesters into monoesters. Therefore, phtha-
late body burden can be estimated through measurement
of phthalate metabolites in the urine.Table 2 Risk assessment of phthalates (reprinted by permission
Country Committee mg/kg/d
DEP USA ATSDR 7
5
US-EPA 0.8
DnBP USA ATSDR 0.5
US-EPA 0.1
Canada Health Canada 0.06
EU CSTEE 0.1
BBzP USA US-EPA 0.2
EU CSTEE 0.2
DEHP USA US-EPA 0.020
ATSDR 0.100
0.060
Canada Health Canada 0.044
EU CSTEE 0.050
ECB/EU 0.020
0.025
0.048
DnOP USA ATSDR 3
0.4
EU CSTEE 0.37
DiNP EU CSTEE 0.15
DiDP EU CSTEE 0.25
ATSDRZ Agency for Toxic Substances and Disease Registry; BBzPZ b
Ecotoxicity and the Environment; DEP Z diethyl phthalate; DnBP
DnOP Z di-n-octyl phthalate; DiNP Z di-iso-nonyl phthalate; DiDP
EPA Z Environmental Protection Agency; MRL Z minimal risk level;Tolerable daily intake/reference dose level/
minimal risk level
Table 2 shows risk assessments of phthalates, performed by
different expert panels in Europe and America.2 Based on
the no observed adverse effect level (NOAEL) or lowest
observed adverse effect level (LOAEL) derived from animal
studies, the Scientific Committee on Toxicity, Ecotoxicity
and the Environment obtained tolerable daily intake (TDI)
values for phthalates. Phthalates, which are commonly
used such as DEHP and DINP, are those with the lowest
calculated TDI values.2 The minimal risk level (MRL),
derived by the Agency for Toxic Substances and Disease
Registry are obtained by consideration of the most sensitive
endpoint and the most sensitive species, using NOAEL or
LOAEL and taking uncertainty factors into account. Thus,
the lowest MRL of 0.06 mg/kg/day has been calculated for
chronic exposure to DEHP, based on a NOAEL of 5.8 mg/kg
for adverse testicular effects, and an intermediate duration
oral MRL based on an LOAEL of 140 mg/kg bodyweight for
reduced fertility.2 The US Environmental Protection Agency
has derived a chronic reference dose level of 0.02 mg/day
for DEHP based on an LOAEL of 19 mg/kg/day for hepatic
effects in guinea pigs.2
Toxicity of phthalates in animal models
In mammalian development, the fetus is set to develop into
a female (Fig. 2).7 This is not always the default pathway,from Elsevier: Int J Hyg Environ Health2).
MRL/TDI/RfD
MRL acute oral exposure
MRL chronic oral exposure
RfD chronic exposure
MRL acute oral exposure
RfD chronic exposure
TDI
TDI
RfD chronic exposure
TDI
RfD chronic exposure
MRL intermediate duration exposure
MRL chronic exposure
TDI
TDI
TDI for newborns <3 mo, women in childbearing age
TDI infants 3 to <12 mo
TDI population except newborns, infants, women
in childbearing age
MRL acute oral exposure
MRL intermediate duration exposure
TDI
TDI
TDI
utyl benzyl phthalate; CSTEEZ Scientific Committee on Toxicity,
Z di-n-butyl phthalate; DEHP Z di(2-ethylhexyl) phthalate;
Z di-iso-decyl phthalate. ECB Z European Chemicals Bureau;
TDI Z tolerable daily intake; RfD Z reference dose.
Figure 2 Sex determination and sexual differentiation in humans (reprinted by permission from Elsevier: Best Pract Res Clin
Endocrinol Metab7). The preset program is for the sexually undifferentiated fetus to follow the female development pathway;
diversion from this pathway is achieved by formation of the testes. Hormone production by the testes is then responsible for the
masculinization process that is responsible for most of the sexual differentiation. As a consequence, male development, but not
female development, is completely hormone-dependent and is, thus, inherently more susceptible to endocrine disruption.
Food safety and phthalate plasticizer 675but in general, the external genitalia and internal repro-
ductive tract develop into female organs. Thus, the Mulle-
rian ducts persist internally and develop into the fallopian
tubes, uterus and upper part of the vagina, whereas the
Wolffian ducts, which otherwise develop into the epidid-
ymis, vas deferens, and seminal vesicles (in the male),
spontaneously degenerate.7 For a fetus to develop into
a male, the female development pathway must be dis-
rupted. This intervention is initiated by activation of the
Sry gene on the Y chromosome. Through processes that are
incompletely understood, but which involve activation of
factors such as WT1, SF1, and in particular Sox9, the
undifferentiated gonad begins to become a testis via
differentiation of the Sertoli cells. This is followed by
a number of events that result in the formation of semi-
niferous cords containing premeiotic germ cells and outside
of and between the seminiferous cords, hormonally active
Leydig cells. In this way, a testis is formed. Completion of
testis formation does not, however, lead automatically to
development along the male development pathway. For
this to happen, hormonal intervention is required on three
separate but interrelated fronts, involving the production
and secretion by the testis of anti-Mullerian hormone,
testosterone, and insulin-like factor 3. Therefore, it should
be apparent that becoming a phenotypic male is not just
about forming a testis; it is very largely a hormone-
dependent process, with each of the hormones playing
a role to divert development from the female pathway.7 In
rats, for example, the programming window for testis
development occurs during the last week of gestation
(gestational days 15.5e21.5). This programming window is
divided into three distinct phases: early, middle, and late.8
The early phase, between gestational days 15.5 and 17.5, is
the period when testosterone production is initiated. The
middle phase, gestational days 17.5e19.5, is immediatelybefore the period of morphological differentiation of the
male reproductive system, and corresponds to the period
when testosterone production in the male fetus peaks (at
gestational day 19). The late phase between gestational
days 19.5 and 21.5 is the period when reproductive cells
morphologically differentiate (prostatic budding and Wolf-
fian duct differentiation).8
The female phenotype is the default pathway, there-
fore, impairment of testosterone production or action
before the late phase may lead to feminizing characteris-
tics such as reduced anogenital distance and hypospadias.8
Unlike other antiandrogens, which act by binding to the
androgen receptors, and to inhibit their ability to respond
to androgens, phthalates disrupt the development of
androgen-dependent structures, mainly by inhibiting fetal
testicular testosterone biosynthesis.9e11 This effect is
mediated by changes in gene expression of enzymes and
proteins involved in testosterone production by fetal Leydig
cells, including the steroidogenic acute regulatory protein,
which participates in the transport of cholesterol to the
inner mitochondrial membrane, which is the rate-limiting
step in the steroidogenic pathway.12,13 It has recently
been shown that the expression of another product of the
fetal Leydig cells, insulin-like factor 3, is reduced in
phthalate-exposed animals.10 Such an effect might explain
the incidence of retention of testes in the abdomen
(cryptorchidism) following phthalate exposure, because
insulin-like factor 3 is involved in the initial stages of
testicular descent into the scrotum.10,14
Some phthalates, such as DnBP,15,16 DiBP,17e19
DEHP,9,20,21 BBzP22,23 and DiNP,20,24 are developmental
and reproductive toxicants. They modulate the endogenous
production of fetal testicular testosterone and influence
insulin-like factor 3 and follicle-stimulating hormone
production.25 Critical effects are related to functional and
676 T.-H. Yen et al.structural impairment of male reproduction and develop-
ment,14,20,26 and manifest in malformations of the epi-
didymis and the external genitalia (hypospadias),
undescended testes (cryptorchidism), impaired spermato-
genesis, and a general reduction of male fertility.15
Phthalates also cause signs of feminization (retention of
nipples/areolae in male rodents) and a reduced anogenital
distance as a first indication of general demasculiniza-
tion.16,23 This group of symptoms in animals is called
phthalate syndrome.14,27
Phthalates exhibit low acute toxicity with lethal dose 50
values of 1e30 g/kg body weight or with even higher
concentrations.2 In short- and long-term rodent studies,
dose-related adverse effects have been found in liver,
kidney and, for selected phthalates, thyroid gland and
testis. All phthalates have been tested negative for muta-
genicity or genotoxicity. With regard to carcinogenicity, the
activity of DEP is questionable; for DiNP, no hints for car-
cinogenicity have been observed; DBP seems to be associ-
ated with tumor promoting activity; and exposure to DEHP
produces hepatocellular carcinoma in rodents, along with
a variety of other hepatocellular effects such as prolifera-
tion of peroxisomes and mitochondria, increased Cyp4A1
and peroxisomal palmitoyl CoA (PCoA) activity, liver tissue
proliferation, and suppression of apoptosis.2 Most of these
effects are mediated by an induction of the peroxisome
proliferator-activated receptor (PPAR)-a.28 In PPAR-
a knockout mice, administration of DEHP does not result in
hepatocellular effects. For several reasons, for example,
differences in PPAR-a density, regulation and signaling
pathways, adverse effects associated with PPAR activation
in rodents do not occur in humans. Nevertheless, the US
Environmental Protection Agency has determined that
DEHP is a probable human carcinogen. Furthermore, DEHP
is included in the list of Group 2B carcinogens by the
International Agency for Research on Cancer,29 and listed
by the Environmental Protection Administration Executive
Yuan, R.O.C. (Taiwan) as a Category 4 toxic chemical.Toxicity of phthalate in human infants
and children
The spectrum of effects obtained following perinatal
exposure of male rats to phthalates has remarkable simi-
larities with human testicular dysgenesis syndrome.
According to Skakkebaek et al,30 human testicular dysgen-
esis syndrome is characterized by low sperm counts,
cryptorchidism, hypospadias, and testicular cancer, and the
clinical expression of these symptoms may vary with the
severity of the syndrome. Accordingly, less severe mani-
festations would result in impaired spermatogenesis, while
other symptoms, such as testicular cancer, may be present
in more severely affected individuals.30
Several epidemiological studies have examined the rela-
tionship between phthalate exposure and adverse outcomes
in infants and children (Table 3).31,53e58,60e64 In one of the
pioneering studies, Swan et al32 have found that urinary
concentrations of four phthalate metabolites [mono-ethyl
phthalate (MEP), mono-n-butyl phthalate (MBP), mono-
benzyl phthalate (MBzP) and mono-iso-butyl phthalate
(MiBP)] were inversely related to the anogenital index. Theanogenital index was defined as anogenital distance divided
byweight at examination. After adjusting for age, p values for
regression coefficients ranged from 0.007 to 0.097. Compar-
ison between boys with a prenatal MBP concentration in the
highest quartile with those having a prenatal MBP concen-
tration in the lowest quartile yielded an odds ratio (OR) for
a shorter than expected anogenital index of 10.2 [95% confi-
dence interval (CI)Z 2.5e42.2]. The corresponding ORs for
MEP, MBzP and MiBP were 4.7, 3.8 and 9.1, respectively
(p < 0.05). Furthermore, the age-adjusted anogenital index
decreased significantly as the phthalate score increased
(p value for slope Z 0.009). The association between male
genital development and observed phthalate exposure is
consistent with the phthalate-related syndrome of incom-
plete virilization. The median concentrations of phthalate
metabolites that are associated with a short anogenital index
and incomplete testicular descent are below the concentra-
tions found in one-quarter of the female population in the
United States, on the basis of a nationwide sample. These
data support the hypothesis that prenatal phthalate exposure
at environmental levels can adversely affect male reproduc-
tive development in humans.32 Main et al33 have investigated
whether phthalatemonoester contamination of humanbreast
milk had any influence on the postnatal surge of reproductive
hormones that signals testicular dysgenesis in newborn boys.
All phthalate monoesters were found in breast milk with
large variations: mono-methyl phthlate (MMP) 0.10
(< 0.01e5.53 mg/L); MEP 0.95 (0.07e41.4 mg/L); MBP 9.6
(0.6e10,900 mg/L); MBzP 1.2 (0.2e26 mg/L); mono-
(2-ethylhexyl) phthalate (MEHP) 11 (1.5e1410 mg/L); and
mono-iso-nonyl phthalate (MiNP) 95 (27e469 mg/L). Finnish
breastmilk had higher concentrations ofMBP,MBzPandMEHP,
and Danish breast milk had higher values for MiNP
(p Z 0.0001e0.056). No association was found between
phthalate monoester levels and cryptorchidism. However,
MEP and MBP showed positive correlations with sex-hormone
binding globulin (r Z 0.323, p Z 0.002 and r Z 0.272,
pZ 0.01, respectively); MMP, MEP, and MBP with luteinizing
hormone:free testosterone ratio (r Z 0.21e0.323,
p Z 0.002e0.044) and MiNP with luteinizing hormone
(rZ 0.243, pZ 0.019). MBP was negatively correlated with
free testosterone (rZ e0.22, pZ 0.033). The findings were
in line with other human data showing incomplete virilization
in infant boys prenatally exposed to phthalates.33
Latini et al34 have measured serum DEHP and MEHP
concentrations in the cord blood of 84 newborns and found
detectable cord blood DEHP and/or MEHP concentrations in
88.1% of the samples. Either DEHP or MEHP was present in
65 of 84 (77.4%) of the examined samples. Mean concen-
trations of DEHP and MEHP were 1.19  1.15 mg/mL
(95% CI Z 0.93e1.44) and 0.52  0.61 mg/mL
(95% CI Z 0.39e0.66), respectively. MEHP-positive
newborns showed a significantly lower gestational age
compared with MEHP-negative infants (pZ 0.033). Logistic
regression analysis results indicated a positive correlation
between absence of MEHP in cord blood and gestational age
at delivery (OR Z 1.50, 95% CI Z 1.013e2.21; p Z 0.043).
These findings confirmed that human exposure to DEHP can
begin in utero and suggest that phthalate exposure is
significantly associated with a shorter pregnancy dura-
tion.34 Colon et al35 have attempted to identify pollutants
in the serum of Puerto Rican girls with premature breast
Table 3 Health outcomes in infants and children associated with phthalate concentration in biological or environmental samples (reprinted by permission from Elsevier:
Environ Res31).
System Timing of exposure Sex Outcome Phthalate or metabolite
(measured in urine unless
otherwise noted)
Reference
Reproductive Prenatal Male/female Shorter gestational age at birth MEHP (in cord blood) 34
Prenatal (mean age:
12.6 mo at examination)
Male Shorter anogenital distance MEHP, MEOHP, MEHHP, MEP,
MBP
31,32
Reduced penile size MEHP
Incomplete testicular descent MEHP, MEHHP, MEOHP
Lactation (mean age 3 mo) Male Increased sex hormone binding
globulin
MEP, MBP 33
Increased luteinizing hormone/
free testosterone
MMP, MEP, MBP
Increased luteinizing hormone MiNP
Decreased free testosterone MBP
Early childhood Female Premature thelarche DEHP (in serum) 35
Respiratory, allergy
and asthma
Childhood Male/female Rhinitis and eczema BBzP (in house dust) 36
Asthma DEHP (in house dust)
Wheezing, rhinitis and eczema DEHP (in house dust) 37
BBzP Z butyl benzyl phthalate; DEHP Z di(2-ethylhexyl) phthalate; MBP Z mono-butyl phthalate; MEHHP Z mono-(2-ethyl-5-hydroxylhexyl) phthalate; MEHP Z mono-(2-ethylhexyl)
phthalate; MEOHP Z mono-(2-ethyl-5-oxohexyl) phthalate; MEP Z mono-ethyl phthalate; MiNP Z mono-isononyl phthalate; MMP Z mono-methyl phthalate.
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678 T.-H. Yen et al.development or thelarche. A total of 41 serum samples
from thelarche patients and 35 control samples were
analyzed. No pesticides or their metabolite residues were
detected in the serum of the study or control subjects.
Significantly high levels of phthalates (DMP, DEP, DBP and
DEHP) and its major metabolite MEHP were identified in 28
(68%) samples from thelarche patients. Of the control
samples analyzed, only one showed significant levels of
mono-iso-nonyl phthalate. This study suggests a possible
association between plasticizers with known estrogenic and
antiandrogenic activity and the cause of premature breast
development in a human female population.35
Bornehag et al36 have investigated possible associations
between persistent allergic symptoms in children and the
concentration of phthalates in dust collected from their
homes. Out of a cohort of 10,852 children, 198 cases with
persistent allergic symptoms and 202 controls without
allergic symptoms were selected. Higher median concen-
trations of BBzP in dust were found among cases than
among controls (0.15 vs. 0.12 mg/g dust). Analysis of the
case group by symptoms showed that BBzP was associated
with rhinitis (pZ 0.001) and eczema (pZ 0.001), whereas
DEHP was associated with asthma (p Z 0.022). Further-
more, doseeresponse relationships for these associations
were supported by trend analyses. This study has shown
that phthalates, within the range of what is normally found
in indoor environments, are associated with allergy symp-
toms in children.36 Finally, Kolarik et al37 have investigated
the associations between allergy symptoms in children and
the concentration of phthalate esters in settled dust
collected from children’s homes in Sofia and Burgas, Bul-
garia. A total of 102 children (2e7 years of age) had
symptoms of wheezing, rhinitis, and/or eczema in the
preceding 12 months (cases), and 82 were nonsymptomatic
(controls). A higher concentration of DEHP was found in the
homes of case children than in those of controls (1.24 vs.
0.86 mg/g dust). The concentration of DEHP was signifi-
cantly associated with wheezing in the preceding 12 months
(p Z 0.035). A doseeresponse relationship was found
between DEHP concentration and case status and between
DEHP concentration and wheezing in the preceding 12
months. The study established a potential association
between the concentration of DEHP in indoor dust and
wheezing among preschool children in Bulgaria.37
Apart from the list in Table 2, recent epidemiological
studies also have suggested possible associations between
phthalate exposure and shorter gestational age,38,39 shorter
anogenital distance,40,41 precocious puberty,42 pubertal
gynecomastia,43 premature thelarche,44 low birth weight,45
attention deficit hyperactivity disorder,46,47 low intelli-
gence quotient,48 thyroid dysfunction and growth retarda-
tion,49 and hypospadias50 in infants and children.
The clinical significant of anogenital distance has been
explored in two recent studies. Mendiola et al51 have found
that anogenital distance (measured from anus to the
posterior base of the scrotum) is associated with sperm
concentration, motility, morphology, total sperm count
and total motile count (p Z 0.002e0.048). Men with ano-
genital distance below (compared to above) the median
were 7.3 times more likely (95% CI Z 2.5e21.6) to have
a low sperm concentration (<20  106/mL).51 Eisenberg at
al52 also have found that infertile men possess significantlyshorter mean anogenital distance and penile length
compared to fertile controls (anogenital distance: 31.8
vs.44.6 mm, penile length: 107.1 vs.119.5 mm, p < 0.01).
On both unadjusted and adjusted linear regression, ano-
genital distance was significantly correlated with sperm
density and total motile sperm count. After adjusting for
demographic and reproductive variables, for each 1-cm
increase in male anogenital distance, the sperm density
increases by 4.3 million/mL (95% CI Z 0.53e8.09 million/
mL, p Z 0.03) and the total motile sperm count increases
by 6.0 million sperm (95% CI Z 1.34e10.58 million,
p Z 0.01).52Toxicity of phthalate in adults
Clinical studies that have explored phthalate adverse
effects in adults are presented in Table 4.31 Duty et al53
have explored whether environmental levels of phthalates
are associated with altered semen quality in humans. A
doseeresponse relationship was found between tertiles of
MBP and sperm motility (OR per tertile Z 1.0, 1.8, 3.0;
p value for trend Z 0.02) and sperm concentration (1.0,
1.4, 3.3; p value for trend Z 0.07). In addition, there was
a doseeresponse relationship between tertiles of MBzP and
sperm concentration (1.0, 1.4, 5.5; p value for
trend Z 0.02).53 In another study, Duty et al54 have
investigated whether environmental levels of phthalates
were associated with altered DNA integrity in human
sperm. One hundred and sixty-eight subjects were
recruited from the Massachusetts General Hospital. For an
interquartile range increase in specific gravity-adjusted
MEP level, the comet extent of the sperm increased
significantly by 3.6 mm (95% CI Z 0.74e6.47); the tail
distributed moment also increased by 1.2 um (95%
CIZ e0.05 to 2.38) but was of borderline significance. The
data demonstrated that urinary MEP was associated with
increased DNA damage in sperm.54 Duty et al55 have also
investigated the association between environmental levels
of phthalates and altered reproductive hormone levels in
adult men. An interquartile range change in MBzP exposure
was significantly associated with a 10% (95% CI Z e16 to
e4) decrease in follicle-stimulating hormone concentra-
tion. In addition, an interquartile range change in MBP
exposure was associated with a 4.8% (95% CI Z 0e10)
increase in inhibin B, but this was of borderline signifi-
cance. Although the researchers found associations
between MBP and MBzP urinary concentrations and altered
levels of inhibin B and follicle-stimulating hormone, the
hormone concentrations did not change in the expected
patterns. Therefore, it is unclear whether these associa-
tions represent physiologically relevant alterations in these
hormones, or whether they represent associations found as
a result of conducting multiple comparisons.55
In a later study, Hauser et al56 recruited 463 male
partners of subfertile couples who presented for semen
analysis to the Massachusetts General Hospital. There were
doseeresponse relationships of MBP with low sperm
concentration (OR per quartile adjusted for age, abstinence
time, and smoking status Z 1.00, 3.1, 2.5, 3.3; p value for
trend Z 0.04) and motility (1.0, 1.5, 1.5, 1.8; p value for
trend Z 0.04). There was suggestive evidence of an
Table 4 Health outcomes in adults associated with phthalate concentration in biological samples (reprinted by permission
from Elsevier: Environ Res31).
System Sex Outcome Phthalate or metabolite
(measured in urine unless
otherwise noted)
Reference
Reproductive Male Increased sperm DNA damage MEP, MEHP 57
Increased sperm DNA damage MEP 54
Decreased sperm motility MBP 53, 56
Decreased sperm
concentration
MBP, MBzP 53, 56
Male Decreased sperm morphology DEHP in semen samples 60
Male Decreased free testosterone
and increased luteinizing
hormone/free testosterone
MBP 61
Male Decreased follicle-stimulating
hormone
MBzP 55
Male Decreased motility and
reduced luteinizing hormone
MEP 58
Respiratory and immune
(including allergy and
asthma)
Male Decreased pulmonary function MEP, MBP 62
Metabolic Male Increased waist circumference MBzP, MEHHP MEOHP, MEP 63
Increased insulin resistance MBP, MBzP MEP
Thyroid Male Thyroid (decreased
triiodothyronine and thyroxine)
MEHP 64
DEHP Z di(2-ethylhexyl) phthalate; MBP Z mono-butyl phthalate; MBzP Z mono-benzyl phthalate; MEHP Z mono-(2-ethylhexyl)
phthalate; MEHHP Z mono-(2-ethyl-5-hydroxylhexyl) phthalate; MEOHP Z mono-(2-ethyl-5-oxohexyl) phthalate; MEP Z mono-ethyl
phthalate.
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sperm concentration (1.00, 1.1, 1.1, 1.9; p value for
trend Z 0.13). There were no relationships between MEP,
MMP and DEHP metabolites and the semen parameters.
Therefore, the study confirmed previous results that
showed a relationship of altered semen quality and expo-
sure to MBP at general population levels.56 In another study
involving 379 men from an infertility clinic,57 urinary
concentrations of phthalate metabolites were measured.
Sperm DNA damage measurements included comet extent,
percentage of DNA in tail, and tail distributed moment.
MEP, a metabolite of DEP, was associated with increased
DNA damage. MEHP, a metabolite of DEHP, was associated
with DNA damage after adjustment for the oxidative DEHP
metabolites. After adjustment for mono-(2-ethyl-5-
hydroxylhexyl) phthalate (MEHHP), for an interquartile
range increase in urinary MEHP, comet extent increased by
17.3% (95% CI Z 8.7e25.7%), tail distributed moment
increased by 14.3% (95% CIZ 6.8e21.7%) and percentage of
DNA in tail increased by 17.5% (95% CI Z 3.5e31.5%).
Therefore, sperm DNA damage was associated with MEP and
MEHP after adjusting for DEHP oxidative metabolites.57
In a Swedish study,58 urine, serum and semen samples
were collected from 234 young men at the time of their
medical conscript examination. Semen volume, sperm
concentration, and motility were measured, together with
sperm chromatin integrity (sperm chromatin structure
assay) and biochemical markers of epididymal and prostatic
function. For MBP, MBzP and MEHP, no clear pattern of
associations was observed with any of the reproductive
biomarkers. Subjects within the highest quartile for MEPhad fewer motile sperm (mean difference Z 8.8%; 95%
CI Z 0.8e17), more immotile sperms (8.9%; 95%
CI Z 0.3e18), and lower luteinizing hormone values
(0.7 IU/L; 95% CI Z 0.1e1.2), but there was no suggestion
of harmful effects for most other endpoints. Phthalic acid
actually was associated with improved reproductive func-
tion, as measured by several markers. The observed weak
associations between one phthalate biomarker and
impairment of a few aspects of reproductive function
biomarkers58 were not consistent with the results from
a study in the United States.59
In a Chinese study, Zhang et al60 monitored the level of
phthalates in human semen samples and analyzed the
relationship between phthalate levels and semen parame-
ters. Three phthalates (DEP, DBP and DEHP) were detected
in most of the biological samples, with median levels of
0.30 mg/L (0.08e1.32 mg/L) in semen specimens. There
was a significant positive association between liquefied
time of semen and phthalate concentrations in semen. The
correlation coefficients were 0.456 for DEP, 0.475 for DBP,
and 0.457 for DEHP. There was no significant difference
between phthalate concentrations in semen and sperm
density or livability, although the correlation coefficients
were negative. These results suggest that people who
reside in Shanghai are exposed to phthalates, especially to
DBP and DEHP. Although the level of phthalates is relatively
mild, an association of phthalate levels and reduced quality
of human semen has been demonstrated in the Chinese
study.60 In another study, Pan et al61 examined urine and
blood samples from 74 male workers who worked at
a factory that produced unfoamed PVC flooring, and were
680 T.-H. Yen et al.exposed to DBP and DEHP, and compared the samples to
control samples from 63 male construction workers.
Compared to the unexposed workers, the exposed had
substantially and significantly elevated concentrations of
MBP (644.3 vs. 129.6 mg/g creatinine, p < 0.001) and MEHP
(565.7 vs. 5.7 mg/g creatinine, p < 0.001). Free testos-
terone was significantly lower (8.4 vs. 9.7 mg/g creatinine,
p Z 0.019) in exposed workers than in unexposed. Free
testosterone was negatively correlated to MBP (rZ e0.25,
pZ 0.03) and MEHP (rZ e0.19, pZ 0.095) in the group of
exposed workers. Regression analyses revealed that free
testosterone decreased significantly with increasing total
phthalate ester score (the sum of quartiles of MBP and
MEHP; rZ e0.26, pZ 0.002). The data confirmed a modest
and significant reduction of serum-free testosterone in
workers with higher levels of urinary MBP and MEHP
compared to unexposed workers.61
Hoppin et al62 have assessed the association between
phthalate exposure and four pulmonary function param-
eters [forced vital capacity (FVC), forced expiratory
volume at 1 second (FEV1), peak expiratory flow (PEF),
and maximum mid-expiratory flow] among the 240 adult
participants of the Third National Health and Nutrition
Examination Survey (NHANES III) with urinary phthalate
data. MBP was significantly associated with decrements in
three measures of pulmonary function (FVC, FEV1 and
PEF) in men but not in women. Between the 25th to the
75th percentile in the MBP level among men, the FEV1
decreased to 112 mL (standard error Z 51, p Z 0.03).
MEP levels were associated with lower FVC and FEV1
values in men. MEHP levels were not adversely associated
with any of the pulmonary function parameters evalu-
ated. The results suggested that MBP and MEP, but not
MEHP, might influence pulmonary function among adult
men.62
Stahlhut et al63 have investigated phthalate exposure
and its associations with abdominal obesity and insulin
resistance. Subjects were US adult male participants of the
National Health and Nutrition Examination Survey (NHANES)
1999e2002. Six phthalate metabolites were modeled with
prevalent exposure and known or suspected antiandrogenic
activity as predictors of waist circumference and log-
transformed homeostatic model assessment (HOMA;
a measure of insulin resistance) using multiple linear
regression; adjusted for age, race/ethnicity, fat and total
calorie consumption, physical activity level, serum creati-
nine, and urine creatinine (model 1); and were adjusted for
model 1 covariates plus measures of renal and hepatic
function (model 2). In model 1, four metabolites were
found to be associated with increased waist circumference
(MBzP, MEHHP, MEOHP and MEP; p  0.013) and three with
increased HOMA (MBP, MBzP and MEP; p  0.011). When
also adjusted for renal and hepatic function, parameter
estimates declined, but all significant results were
confirmed, except for HOMA-MBP. The findings suggest that
concentrations of several prevalent phthalate metabolites
have significant correlations with abdominal obesity and
insulin resistance.63 Meeker et al64 have collected concur-
rent samples of urine and blood from 408 men in the United
States. An inverse association was found between MEHP
urinary concentrations and free thyroxine and triiodothy-
ronine serum levels, although the relationships did notappear to be linear when MEHP concentrations were cate-
gorized by quintiles. There was evidence of a plateau at the
fourth quintile, which was associated with a 0.11 ng/dL
decrease in free thyroxine (95% CI: e0.18 to e0.03) and
a 0.05 ng/mL decrease in triiodothyronine (95% CI: e0.10 to
0.01) compared with the first (lowest) MEHP quintile. The
inverse relationship between MEHP and free thyroxine
remained when adjusted for oxidative metabolite concen-
trations; this simultaneously demonstrated a suggestive
positive association with free thyroxine. Therefore, urinary
MEHP concentrations may be associated with altered free
thyroxine and/or total triiodothyronine levels in adult
men.64
Apart from the list in Table 3, recent epidemiological
studies have also suggested possible associations between
phthalate exposure and endometriosis,65e70 uterine leio-
myomas,66 breast cancer,71 obesity,72 poor semen quality,73
hyperprolactinemia,74 and low circulating sex steroid
hormone levels75 in adults.Phthalate exposure-related studies in Taiwan
The number of phthalate-related scientific publications
from Taiwan has increased greatly over the past 5
years.76e82 It is not certain if this reflects the adverse
health effects following illegal addition of DEHP and DiNP to
clouding agents in foods and beverages over the past two
decades. In 2007, Huang et al76 examined the association
between phthalate exposure and thyroid hormones in
pregnant women. Serum and spot urine samples were
collected from 76 pregnant women at second trimester.
Urinary MBP, MEP and MEHP (median levels Z 81.8, 27.7
and 20.6 ng/mL, respectively) were the predominant
substances. Significant mild negative correlations were
found between thyroxine and urinary MBP (r Z e0.248,
p < 0.05), and between free thyroxine and urinary MBP
(rZ e0.368, p < 0.05). After adjusting for age, body mass
index and gestation, urinary MBP levels showed negative
associations with free thyroxine and thyroxine (free
thyroxine: beta Z e0.110, p < 0.001; thyroxine:
beta Z e0.112, p Z 0.003). Therefore, exposure to DBP
might affect thyroid activity in pregnant women, but how
DBP affects thyroid function remains unclear.76 Chen et al77
have examined the migration level of phthalate from PVC
films by simulating food handling. To estimate a worst-case
scenario of phthalate migration, food was covered with PVC
films and then microwaved. The DEHP levels in food
increased significantly after heating. The calculated intake
of phthalates after heating and the percentage of the TDI
(based on a 60 kg body weight) from eating a 400-g meal
were 1705.6 mg and 92.2% for DEHP. Determinations of
urinary metabolites from 60 subjects also revealed that
MMP, MBP and MEHP were detectable in >90% of samples.
The results reflected the extensive use of plastic materials
in Taiwan.77 Huang et al78 also have evaluated the possible
association between maternal urine excretion, exposure of
the fetus to phthalates in amniotic fluid, and health of
newborns. The median levels of three phthalate mono-
esters in urine and amniotic fluid were 78.4 and 85.2 ng/mL
for MBP; 24.9 and 22.8 ng/mL for MEHP; 19.8 and not
detected for MEP. A significant positive correlation was
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amniotic fluid MBP (r2 Z 0.156, p < 0.05) in all infants. In
female infants, a significant negative correlation was found
between amniotic fluid MBP, anogenital distance
(r Z e0.31, p < 0.06), and the anogenital index adjusted
for birth weight (r Z e0.32, p < 0.05). The data showed
that in utero exposure to phthalates, in general, had
antiandrogenic effects on the fetus.78 In another study,
Chou et al79 recruited girls in early puberty: 30 with
premature thelarche, 26 with central precocious puberty,
and 33 normal controls. The mean urine levels of MMP were
significantly higher in the premature thelarche group
(96.5  134.0 ng/mL) than in the control group (26.4  30.0
ng/mL; p Z 0.005). The levels of MBP correlated with the
intake of seafood and drink, and the use of plastic cups.
The levels of MEHP correlated with the intake of seafood
and meat and exposure to plastic wrapping. The signifi-
cantly higher MMP concentrations in the premature the-
larche girls suggested that phthalate might be one of the
environmental causes of early puberty in Taiwan.79 Huang
et al80 have conducted another caseecontrol study to
determine whether estrogen-dependent diseases are asso-
ciated with phthalate exposure and how the glutathione S-
transferase M1 (GSTM1; a major detoxification enzyme)
genotype might modulate the risk. Patients with leiomyoma
had significantly higher level of total urinary MEHP (52.1 vs.
18.9 mg/g creatinine, p < 0.05) than the controls, whereas
patients with endometriosis had an increased level of
urinary MBP (94.1 vs. 58.0 mg/g creatinine, p < 0.05).
Subjects with the GSTM1 null genotype had significantly
higher risk for adenomyosis relative to those with the
GSTM1 wild-type genotype (OR Z 5.30; 95%
CI Z 1.22e23.1), even after adjustment for age and
phthalate exposure. Subjects who carried the GSTM1 null
genotype and had a high urinary level of MEHP showed
a significantly increased rate of adenomyosis (OR Z 10.4;
95% CI Z 1.26e85.0) and leiomyoma (OR Z 5.93; 95%
CI Z 1.10e31.9) after adjustment for age, compared to
those with the GSTM1 wild-type genotype and low urinary
levels of MEHP. These results suggest that both the GSTM1
null genotype and phthalate exposure are associated with
adenomyosis and leiomyoma.80 Lin et al81 have assessed the
possible association between maternal phthalate exposure
and cord sex steroid hormones in pregnant women and their
newborns among the general population. A total of 155
maternal and infant pairs were recruited and analyzed. No
significant correlation was found between steroid hormones
and phthalate metabolites for male newborns, although
there was a marginally significant correlation between MMP
and estradiol. After adjusting for maternal age, estradiol
levels in cord serum from male newborns were not corre-
lated with maternal urinary phthalate metabolites. In
female newborns, the maternal urinary levels of MEHP and
5OH-MEHP were negatively correlated with the free
testosterone and free testosterone/estradiol levels in cord
serum, with Pearson correlation coefficients ranging
between e0.24 and e0.29 (p < 0.05). In addition, after the
gestational age was adjusted, the maternal urinary level of
DEHP negatively correlated with the free testosterone and
free testosterone/estradiol levels in cord serum. The data
suggest that maternal exposure to phthalates affect the
status of sex steroid hormones during the fetal andnewborn stages of development.81 In a recent study,82 45
workers were divided into low- and high-DEHP-exposed
groups in accordance with the median levels of DEHP
(23.7 mg/m3) in personal air. In the high-DEHP-exposed
group, significant increases were found in the tendency
for sperm DNA denaturation, DNA fragmentation index, and
propensity for coffee drinking. After adjusting for coffee
drinking, cigarette smoking, and age, personal air concen-
trations of DEHP showed positive associations with DNA
denaturation (b Z 0.038) and DNA fragmentation index
(bZ 0.140) and a negative associations with sperm motility
(b Z e0.227). Therefore, the study demonstrated a link
between the DEHP concentration in ambient air and
adverse effects on sperm motility and chromatin DNA
integrity.82Conclusions
High exposure to phthalates can occur via chronic ingestion
of foods and beverages prepared with phthalate plasticizer-
containing clouding agents. Nevertheless, there are several
basic steps that can help to reduce the burden of phtha-
lates on the body: (1) drink more water to flush out more
phthalates from the body; (2) eat a high-fiber diet to
increase stool bulk and thereby increases phthalate
excretion from the colon; (3) eat more fresh fruits and
vegetables to ingest more vitamin C, a well-known antiox-
idant, which may help to overcome the increase in oxida-
tive stress induced by phthalate exposure that leads to
some adverse health conditions83; (4) eat less fatty food, in
which levels of some phthalates are particularly high
because of their attraction to fat molecules84; (5) eat more
fresh foods and less prepackaged food because DEHP
exposure has been demonstrated to be substantially
reduced in diets restricted to food with limited pack-
aging85; (6) wash hands before eating and drinking to help
reduce oral ingestion of phthalates; (7) do not reheat food
in plastic containers or plastic wrapping in the microwave
because high temperatures may cause phthalates to leach
out of the plastics; (8) avoid using a highly concentrated
personal care product, because phthalates are used to add
texture and luster to hair spray, deodorant, nail polish,
lipstick, perfumes and many other baby products; and (9) in
the case of chronic ingestion of phthalate-contaminated
foods, especially when dietary exposure estimates exceed
the TDI/reference dose level/MRL, stop consumption of the
foods immediately and seek medical advice when in doubt.Acknowledgments
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